Annual Shareholders Equity
$10.77 B
+$122.10 M+1.15%
31 December 2023
Summary:
Eli Lilly and Company annual stockholders equity is currently $10.77 billion, with the most recent change of +$122.10 million (+1.15%) on 31 December 2023. During the last 3 years, it has risen by +$5.13 billion (+90.94%). LLY annual shareholders equity is now -38.91% below its all-time high of $17.63 billion, reached on 31 December 2013.LLY Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$14.24 B
+$678.00 M+5.00%
30 September 2024
Summary:
Eli Lilly and Company quarterly stockholders equity is currently $14.24 billion, with the most recent change of +$678.00 million (+5.00%) on 30 September 2024. Over the past year, it has increased by +$3.02 billion (+26.91%). LLY quarterly shareholders equity is now -22.35% below its all-time high of $18.34 billion, reached on 31 March 2014.LLY Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.1% | +26.9% |
| 3 y3 years | +90.9% | +83.6% |
| 5 y5 years | +9.6% | +321.0% |
LLY Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +90.9% | at high | +83.6% |
| 5 y | 5 years | at high | +313.2% | at high | +446.2% |
| alltime | all time | -38.9% | +385.0% | -22.4% | +541.1% |
Eli Lilly And Company Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $14.24 B(+5.0%) |
| June 2024 | - | $13.56 B(+5.9%) |
| Mar 2024 | - | $12.81 B(+18.9%) |
| Dec 2023 | $10.77 B(+1.1%) | $10.77 B(-4.0%) |
| Sept 2023 | - | $11.22 B(+1.4%) |
| June 2023 | - | $11.06 B(-1.1%) |
| Mar 2023 | - | $11.19 B(+5.1%) |
| Dec 2022 | $10.65 B(+18.6%) | $10.65 B(+5.8%) |
| Sept 2022 | - | $10.07 B(+17.9%) |
| June 2022 | - | $8.54 B(-8.4%) |
| Mar 2022 | - | $9.33 B(+3.9%) |
| Dec 2021 | $8.98 B(+59.2%) | $8.98 B(+15.8%) |
| Sept 2021 | - | $7.76 B(+20.4%) |
| June 2021 | - | $6.44 B(-6.6%) |
| Mar 2021 | - | $6.90 B(+22.3%) |
| Dec 2020 | $5.64 B(+116.4%) | $5.64 B(+16.9%) |
| Sept 2020 | - | $4.83 B(+17.9%) |
| June 2020 | - | $4.09 B(+32.9%) |
| Mar 2020 | - | $3.08 B(+18.1%) |
| Dec 2019 | $2.61 B(-73.5%) | $2.61 B(-22.9%) |
| Sept 2019 | - | $3.38 B(+21.7%) |
| June 2019 | - | $2.78 B(+12.1%) |
| Mar 2019 | - | $2.48 B(-74.8%) |
| Dec 2018 | $9.83 B(-15.2%) | $9.83 B(-24.8%) |
| Sept 2018 | - | $13.08 B(+13.2%) |
| June 2018 | - | $11.56 B(-20.5%) |
| Mar 2018 | - | $14.53 B(+25.3%) |
| Dec 2017 | $11.59 B(-17.2%) | $11.59 B(-22.1%) |
| Sept 2017 | - | $14.89 B(+5.6%) |
| June 2017 | - | $14.10 B(+0.5%) |
| Mar 2017 | - | $14.03 B(+0.2%) |
| Dec 2016 | $14.01 B(-3.9%) | $14.01 B(-10.1%) |
| Sept 2016 | - | $15.59 B(+6.5%) |
| June 2016 | - | $14.64 B(-2.5%) |
| Mar 2016 | - | $15.01 B(+3.0%) |
| Dec 2015 | $14.57 B(-5.2%) | $14.57 B(-4.3%) |
| Sept 2015 | - | $15.22 B(+3.8%) |
| June 2015 | - | $14.67 B(-1.7%) |
| Mar 2015 | - | $14.92 B(-2.9%) |
| Dec 2014 | $15.37 B(-12.8%) | $15.37 B(-13.0%) |
| Sept 2014 | - | $17.67 B(-1.7%) |
| June 2014 | - | $17.98 B(-1.9%) |
| Mar 2014 | - | $18.34 B(+4.0%) |
| Dec 2013 | $17.63 B(+19.4%) | $17.63 B(+4.4%) |
| Sept 2013 | - | $16.89 B(+10.9%) |
| June 2013 | - | $15.23 B(+1.9%) |
| Mar 2013 | - | $14.95 B(+1.2%) |
| Dec 2012 | $14.77 B(+9.0%) | $14.77 B(-8.1%) |
| Sept 2012 | - | $16.06 B(+12.3%) |
| June 2012 | - | $14.31 B(-3.5%) |
| Mar 2012 | - | $14.83 B(+9.5%) |
| Dec 2011 | $13.54 B(+9.0%) | $13.54 B(-10.1%) |
| Sept 2011 | - | $15.06 B(+5.5%) |
| June 2011 | - | $14.28 B(+2.4%) |
| Mar 2011 | - | $13.94 B(+12.2%) |
| Dec 2010 | $12.42 B(+30.4%) | $12.42 B(+21.3%) |
| June 2010 | - | $10.24 B(-2.1%) |
| Mar 2010 | - | $10.46 B(+9.8%) |
| Dec 2009 | $9.52 B(+41.4%) | $9.52 B(-3.8%) |
| Sept 2009 | - | $9.90 B(+15.7%) |
| June 2009 | - | $8.56 B(+10.9%) |
| Mar 2009 | - | $7.72 B(+14.6%) |
| Dec 2008 | $6.74 B(-50.1%) | $6.74 B(-51.0%) |
| Sept 2008 | - | $13.74 B(-6.8%) |
| June 2008 | - | $14.74 B(-1.2%) |
| Mar 2008 | - | $14.91 B(+10.4%) |
| Dec 2007 | $13.50 B(+23.0%) | $13.50 B(+4.3%) |
| Sept 2007 | - | $12.95 B(+12.0%) |
| June 2007 | - | $11.56 B(+0.2%) |
| Mar 2007 | - | $11.53 B(+5.0%) |
| Dec 2006 | $10.98 B | $10.98 B(-15.9%) |
| Sept 2006 | - | $13.05 B(+9.4%) |
| June 2006 | - | $11.93 B(+2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2006 | - | $11.69 B(+8.4%) |
| Dec 2005 | $10.79 B(-1.2%) | $10.79 B(-5.2%) |
| Sept 2005 | - | $11.38 B(+10.9%) |
| June 2005 | - | $10.27 B(-11.5%) |
| Mar 2005 | - | $11.60 B(+6.2%) |
| Dec 2004 | $10.92 B(+11.8%) | $10.92 B(-3.4%) |
| Sept 2004 | - | $11.31 B(+7.7%) |
| June 2004 | - | $10.50 B(-0.6%) |
| Mar 2004 | - | $10.56 B(+8.1%) |
| Dec 2003 | $9.76 B(+18.0%) | $9.76 B(+2.9%) |
| Sept 2003 | - | $9.49 B(+9.2%) |
| June 2003 | - | $8.69 B(-0.5%) |
| Mar 2003 | - | $8.73 B(+5.5%) |
| Dec 2002 | $8.27 B(+16.5%) | $8.27 B(+0.1%) |
| Sept 2002 | - | $8.26 B(+6.6%) |
| June 2002 | - | $7.75 B(+0.6%) |
| Mar 2002 | - | $7.70 B(+8.4%) |
| Dec 2001 | $7.10 B(+17.5%) | $7.10 B(-3.6%) |
| Sept 2001 | - | $7.37 B(+8.9%) |
| June 2001 | - | $6.76 B(+2.6%) |
| Mar 2001 | - | $6.59 B(+9.0%) |
| Dec 2000 | $6.05 B(+20.6%) | $6.05 B(-0.3%) |
| Sept 2000 | - | $6.06 B(+10.0%) |
| June 2000 | - | $5.51 B(-2.6%) |
| Mar 2000 | - | $5.66 B(+12.9%) |
| Dec 1999 | $5.01 B(+13.2%) | $5.01 B(+3.0%) |
| Sept 1999 | - | $4.87 B(+9.3%) |
| June 1999 | - | $4.45 B(-8.4%) |
| Mar 1999 | - | $4.86 B(+9.7%) |
| Dec 1998 | $4.43 B(-4.6%) | $4.43 B(-1.8%) |
| Sept 1998 | - | $4.51 B(-2.9%) |
| June 1998 | - | $4.64 B(-3.2%) |
| Mar 1998 | - | $4.79 B(+3.2%) |
| Dec 1997 | $4.65 B(-23.8%) | $4.65 B(+5.8%) |
| Sept 1997 | - | $4.39 B(-6.0%) |
| June 1997 | - | $4.67 B(-28.9%) |
| Mar 1997 | - | $6.57 B(+7.7%) |
| Dec 1996 | $6.10 B(+12.3%) | $6.10 B(+1.2%) |
| Sept 1996 | - | $6.03 B(+2.3%) |
| June 1996 | - | $5.89 B(+0.8%) |
| Mar 1996 | - | $5.85 B(+7.6%) |
| Dec 1995 | $5.43 B(+1.4%) | $5.43 B(-1.0%) |
| Sept 1995 | - | $5.49 B(-8.2%) |
| June 1995 | - | $5.97 B(+2.4%) |
| Mar 1995 | - | $5.84 B(+9.0%) |
| Dec 1994 | $5.36 B(+17.2%) | $5.36 B(+0.8%) |
| Sept 1994 | - | $5.31 B(+3.2%) |
| June 1994 | - | $5.15 B(+4.2%) |
| Mar 1994 | - | $4.94 B(+8.1%) |
| Dec 1993 | $4.57 B(-6.6%) | $4.57 B(-16.5%) |
| Sept 1993 | - | $5.47 B(+2.2%) |
| June 1993 | - | $5.35 B(+2.6%) |
| Mar 1993 | - | $5.22 B(+6.7%) |
| Dec 1992 | $4.89 B(-1.5%) | $4.89 B(-2.2%) |
| Sept 1992 | - | $5.00 B(-9.9%) |
| June 1992 | - | $5.55 B(+4.7%) |
| Mar 1992 | - | $5.31 B(+6.9%) |
| Dec 1991 | $4.97 B(+43.2%) | $4.97 B(+2.2%) |
| Sept 1991 | - | $4.86 B(+0.0%) |
| June 1991 | - | $4.86 B(+3.7%) |
| Mar 1991 | - | $4.69 B(+35.1%) |
| Dec 1990 | $3.47 B(-7.7%) | $3.47 B(+0.1%) |
| Sept 1990 | - | $3.46 B(-11.1%) |
| June 1990 | - | $3.89 B(-5.1%) |
| Mar 1990 | - | $4.11 B(+9.3%) |
| Dec 1989 | $3.76 B(+16.5%) | $3.76 B(+2.2%) |
| Sept 1989 | - | $3.68 B(+3.4%) |
| June 1989 | - | $3.55 B(+10.2%) |
| Dec 1988 | $3.23 B(+6.0%) | $3.23 B(+6.0%) |
| Dec 1987 | $3.04 B(+11.1%) | $3.04 B(+11.1%) |
| Dec 1986 | $2.74 B(+14.7%) | $2.74 B(+14.7%) |
| Dec 1985 | $2.39 B(+7.5%) | $2.39 B(+7.5%) |
| Dec 1984 | $2.22 B | $2.22 B |
FAQ
- What is Eli Lilly and Company annual stockholders equity?
- What is the all time high annual shareholders equity for Eli Lilly and Company?
- What is Eli Lilly and Company annual shareholders equity year-on-year change?
- What is Eli Lilly and Company quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly shareholders equity year-on-year change?
What is Eli Lilly and Company annual stockholders equity?
The current annual shareholders equity of LLY is $10.77 B
What is the all time high annual shareholders equity for Eli Lilly and Company?
Eli Lilly and Company all-time high annual stockholders equity is $17.63 B
What is Eli Lilly and Company annual shareholders equity year-on-year change?
Over the past year, LLY annual stockholders equity has changed by +$122.10 M (+1.15%)
What is Eli Lilly and Company quarterly stockholders equity?
The current quarterly shareholders equity of LLY is $14.24 B
What is the all time high quarterly shareholders equity for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly stockholders equity is $18.34 B
What is Eli Lilly and Company quarterly shareholders equity year-on-year change?
Over the past year, LLY quarterly stockholders equity has changed by +$3.02 B (+26.91%)